Other News To Note
Wednesday, June 20, 2012
Bavarian Nordic A/S, of Kvistgaard, Denmark, received a $17.9 million five-year contract from the National Institute of Allergy and Infectious Diseases to support development of candidate vaccine technologies to combat the intentional release of pathogens considered a threat to public health.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.